연구성과로 돌아가기

2024 연구자 정보 (697 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Kyoung-Ah
(Kim, KA)
Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Endocrinol & Metab, Goyang, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kim, Nam Hoon
(Kim, NH)
제1저자 Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Anam Hosp, 73 Goryeodae Ro, Seoul 02841, South Korea U-1356-2019
Kim, Nam
0000-0002-9926-1344
Kim, Nam Hoon
[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kim, Sang Soo
(Kim, SS)
Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea U-5269-2017
KIM, SUNG MIN

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kim, Sang Wan
(Kim, SW)
Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Seoul Metropolitan Govt, Seoul, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Boramae Med Ctr, Dept Internal Med, Seoul, South Korea
HNS-5794-2023
Kim, Nam Hoon

[JCR상위 27.0] Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
[JCR상위 27.0] Effects of Endocrine-Disrupting Chemicals on Bone Health
SCIE 27.0 ENDOCRINOLOGY & METABOLISM drbkh@catholic.ac.kr;
kjeun@knu.ac.kr;swkimmd@snu.ac.kr;
Kim, Sang-Yong
(Kim, SY)
Chosun Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Gwangju, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kim, Tae Nyun
(Kim, TN)
Inje Univ, Coll Med, Dept Internal Med, Pusan, South Korea AAV-5521-2020
Kim, Tae

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kim, Won Jun
(Kim, WJ)
Univ Ulsan, Gangneung Asan Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Kangnung, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Koh, Gwanpyo
(Koh, G)
Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Div Endocrinol & Metab,Dept Internal Med, Jeju, South Korea AAV-2707-2020
Koh, Gwanpyo

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kong, Sung Hye
(Kong, SH)
Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
AAJ-7808-2020
Kong, Sung
0000-0002-8791-0909
Kong, Sung Hye
[JCR상위 27.0] Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
[JCR상위 27.0] Effects of Endocrine-Disrupting Chemicals on Bone Health
SCIE 27.0 ENDOCRINOLOGY & METABOLISM drbkh@catholic.ac.kr;
kjeun@knu.ac.kr;swkimmd@snu.ac.kr;
Kwak, Nayoung
(Kwak, N)
Janssen Korea, Market Access, Seoul, South Korea LLK-4732-2024
Kim, Il Young

[JCR상위 27.0] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study SCIE 27.0 MEDICINE, GENERAL & INTERNAL;MEDICINE, RESEARCH & EXPERIMENTAL hankil@ajou.ac.kr;
Kwak, Soo Heon
(Kwak, SH)
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea H-1463-2011
Kwak, Soo Heon

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Lee, Hankil
(Lee, H)
교신저자 Ajou Univ, Coll Pharm, 206 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea
Ajou Univ, Res Inst Pharmaceut Sci & Technol RIPST, Suwon, South Korea
Ajou Univ, Grad Sch, Dept Biohlth Regulatory Sci, Suwon, South Korea

0000-0002-7780-159X
Lee, Hankil
[JCR상위 27.0] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study SCIE 27.0 MEDICINE, GENERAL & INTERNAL;MEDICINE, RESEARCH & EXPERIMENTAL hankil@ajou.ac.kr;
Lee, Jiwon Sophie
(Lee, JS)
Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea

[JCR상위 27.0] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study SCIE 27.0 MEDICINE, GENERAL & INTERNAL;MEDICINE, RESEARCH & EXPERIMENTAL hankil@ajou.ac.kr;
Lee, Juneyoung
(Lee, JEY)
Korea Univ, Dept Biostat, Coll Med, Seoul, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Park, Hyeong-Kyu
(Park, HK)
Soonchunhyang Univ Hosp, Univ Coll Med, Div Endocrinol & Metab, Dept Internal Med, Seoul 04401, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
페이지 이동: